Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
Neurol India. 2022 May-Jun;70(3):983-991. doi: 10.4103/0028-3886.349642.
Maximal safe resection remains the most desired goal of insular glioma surgery. Intraoperative surgical adjuncts provide better tumor visualization and real-time "safety" data but remain limited due to a high cost and limited availability.
To highlight the importance of anatomical landmarks in insular glioma resection and avoidance of vascular complications. We also propose to objectify the onco-functional balance in insular glioma surgery.
Forty-six insular gliomas operated upon by a single surgeon between January 2015 and February 2020 were reviewed, focusing on the operative technique and clinical outcomes. A novel composite postoperative outcome index (CPOI) was designed, comprising the extent of resection and permanent postoperative deficits, and utilized to assess the surgical outcomes.
Gross-total, near-total, and subtotal resections were achieved in 10.9%, 52.1% (n = 24), and 36.9% (n = 17) patients, respectively. The median overall survival (OS) was 20 months (95% CI = 9.56-30.43). CPOI was optimal in 38 patients (82.6%). A well-defined tumor margin (P = 0.01) and surgeon's experience (P = 0.04) were significantly associated with an optimal CPOI. Out of seven (15.2%) patients who developed permanent neurological deficits, three (6.5%) patients had severe disability. Favorable prognostic factors of survival included younger age (<40 years) (P = 0.002), tumors with only frontal lobe extension (P = 0.011), tumors with caudate head involvement (P = 0.04), and non-glioblastoma histology (P = 0.006).
Tumor margin and increasing surgeon experience are critical to an optimal postoperative outcome. Respecting the basi-sulcal plane is key to lenticulostriate artery preservation. Caudate head involvement is a new favorable prognostic factor in insular gliomas.
最大限度地安全切除仍然是岛叶胶质瘤手术最理想的目标。术中手术辅助手段可提供更好的肿瘤可视化和实时“安全”数据,但由于成本高和可用性有限,仍受到限制。
强调在岛叶胶质瘤切除中解剖标志的重要性,避免血管并发症。我们还提议客观评估岛叶胶质瘤手术中的肿瘤功能平衡。
回顾了 2015 年 1 月至 2020 年 2 月由一位外科医生单独进行的 46 例岛叶胶质瘤手术,重点关注手术技术和临床结果。设计了一种新的复合术后结果指数(CPOI),包括切除范围和永久性术后缺陷,并用于评估手术结果。
总切除、近全切除和次全切除分别在 10.9%(n=10)、52.1%(n=24)和 36.9%(n=17)的患者中实现。中位总生存期(OS)为 20 个月(95%CI=9.56-30.43)。CPOI 为 38 例患者(82.6%)最佳。肿瘤边界清晰(P=0.01)和外科医生的经验(P=0.04)与最佳 CPOI 显著相关。在 7 例(15.2%)发生永久性神经功能缺损的患者中,3 例(6.5%)患者有严重残疾。生存的有利预后因素包括年龄较小(<40 岁)(P=0.002)、仅额叶受累的肿瘤(P=0.011)、尾状头受累的肿瘤(P=0.04)和非胶质母细胞瘤组织学(P=0.006)。
肿瘤边界和外科医生经验的增加对于获得最佳术后结果至关重要。尊重基底核平面是保护纹状体动脉的关键。尾状头受累是岛叶胶质瘤的一个新的有利预后因素。